NJ

Nikulkumar Jashvantbhai Patel

Active Director Director DIN 11709253
DIN 11709253 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nikulkumar Jashvantbhai Patel

Data last updated:

Nikulkumar Jashvantbhai Patel is a Director at Xenoventis Pharma Private Limited (since 2026).

DIN 11709253
Primary Designation Director
First Appointment 11 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xenoventis Pharma Private Limited U21000GJ2026PTC177685
Director11 May 20262026Active

Board colleagues of Nikulkumar Jashvantbhai Patel

Directorship timeline

Open interactive timeline →
Xenoventis Pharma Private Limited
Premium access

Shareholding and investment profile for Nikulkumar Jashvantbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikulkumar Jashvantbhai Patel

Nikulkumar Jashvantbhai Patel currently holds 1 directorship: Xenoventis Pharma Private Limited (Director, since 11 May 2026).

Nikulkumar Jashvantbhai Patel was first appointed on 11 May 2026 as Director at Xenoventis Pharma Private Limited.

The current boards of Nikulkumar Jashvantbhai Patel's companies include Dharmesh Laljibhai Patel (Xenoventis Pharma Private Limited), Divya Jain (Xenoventis Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available